Status:
UNKNOWN
Booster Vaccine for Yellow Fever
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Conditions:
Yellow Fever
Eligibility:
All Genders
1-9 years
Phase:
PHASE3
Brief Summary
This is a phase III trial on Children. The investigators will enroll a total of 750 participants in Fajikunda Health Center (Gambia) The aims of the study are * To describe the safety and immunogenic...
Detailed Description
1. Background information and rationale 1.2 Background information Yellow fever (YF) virus is a mosquito-borne flavivirus found in Sub-Saharan Africa and tropical South America. The virus caus...
Eligibility Criteria
Inclusion
- Any child fitting the required age cohorts who has a documented record of having received a primary dose of the Institut Pasteur YF 17D vaccine between 9 and 12 months of age.
- Documented evidence can be either a previous record of YF vaccination with dates in our own trial registers if the child was a previous participant or documented evidence on the Infant Welfare card.
Exclusion
- Any child with a height/length for weight z-score of -3 or below.
- Any child known to be immunocompromised including any child with know vertical exposure to HIV infection.
- Any child with a history of serious adverse event or other contraindication to previous yellow fever vaccination.
- Participants who have an acute illness including abnormal vital signs or a fever of \> 37.5°C will not be vaccinated on the day but may be invited back for rescreening when they have recovered.
Key Trial Info
Start Date :
May 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT05332197
Start Date
May 16 2022
End Date
September 1 2023
Last Update
April 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.